01 ORPHENADRINE CITRATE (1)
01 BAUSCH (1)
01 TABLET, EXTENDED RELEASE;ORAL (1)
01 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (1)
19
Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ORPHENADRINE CITRATE, with a corresponding application number 12157 and regulatory information .
proudly manufactured in the
approval since 1982-01-01
Bausch & Lomb Incorporated's NORFLEX TABLET, EXTENDED RELEASE;ORAL, medication with 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ORPHENADRINE CITRATE.